With new technologies that allow drugs to be tested directly in human biological systems, researchers are beginning to ...

In today’s episode of the pharmaphorum podcast, host Jonah Comstock speaks with Rob DiCicco, vice president of portfolio ...

Roche's oral selective oestrogen receptor degrader (SERD) giredestrant has achieved what the company says is a stellar result ...

By moving early, Novo Nordisk has got in with its price cut ahead of Lilly, whose deal involved dual GLP-1/CIP agonist ...

According to GSK, the programme of 'Grand Challenge' research projects will make use of AI and other cutting-edge ...

Towards that end, the European Society for Medical Oncology (ESMO) has developed a new guidance document that outlines the ...